tradmap

PRLB Financials Proto Labs Inc

15 years of revenue, profit, cash flow and balance-sheet history through FY2025, from SEC filings — with a computed, factual read of the trend. Updated Overview →

Growth & profitability

  • Revenue has grown 4.2% per year over the past 5 years.
  • Net income has grown slower than revenue (-16.0% vs 4.2% per year).
  • Operating margin has contracted, at 4.7% in the latest year.
  • Free cash flow has declined 0.1% per year over the past 5 years.
Revenue & net income
-$103M $215M $533M $0 2012 2013 2015 2017 2019 2021 2023 2025
RevenueNet income
Margins (gross / operating / net)
-21% 18% 56% 0% 2012 2013 2015 2017 2019 2021 2023 2025
GrossOperatingNet
Return on equity & assets (ROE / ROA)
-15% 1% 17% 0% 2012 2013 2015 2017 2019 2021 2023 2025
ROEROA
Free cash flow (CFO − capex)
$0 $34M $69M 2012 2013 2015 2017 2019 2021 2023 2025
Free cash flow
Cash vs total debt
$0 $64M $128M 2012 2013 2015 2017 2019 2021 2023 2025
CashTotal debt
Cash flow: operating / investing / financing
-$124M -$523000 $123M $0 2012 2013 2015 2017 2019 2021 2023 2025
OperatingInvestingFinancing

Key annual figures

FYRevenueNet incomeGross MOp MROEROAFCFTotal debtCash
2025 $533M $21M 44.5% 4.7% 3.2% 2.8% $60M — $111M
2024 $501M $17M 44.6% 4.0% 2.5% 2.2% $69M — $89M
2023 $504M $17M 44.1% 5.6% 2.5% 2.2% $45M — $84M
2022 $488M -$103M 44.1% -20.1% -14.8% -12.9% $40M — $57M
2021 $488M $33M 45.6% 8.3% 4.0% 3.6% $21M — $66M
2020 $434M $51M 50.1% 13.8% 7.9% 6.8% $60M — $128M
2019 $459M $64M 51.3% 17.4% 10.9% 9.4% $54M — $125M
2018 $446M $77M 53.6% 20.0% 14.1% 12.4% $36M — $85M
2017 $344M $52M 56.3% 21.0% 11.2% 10.0% $49M — $37M
2016 $298M $43M 56.0% 20.7% 11.2% 10.3% $44M $0 $69M
2015 — $47M — — 14.2% 12.9% $20M $0 $48M
2014 — $42M — — 15.7% 14.5% — — $43M
2013 — $35M — — 16.7% 15.3% — $363000 $43M
2013 — $28M — — 16.1% 14.6% — — $28M
2012 — $24M — — 15.3% 13.9% $8M — $37M

Valuation over time

How the market has priced PRLB against its own fundamentals since 2023-03 — each month-end's share price set against the most recent annual filing, so the multiple moves as price runs ahead of (or behind) earnings. Split-adjusted.

Price / earnings (P/E)
0.0 53.4 106.8 Mar '23 Sep '23 Mar '24 Sep '24 Mar '25 Sep '25 Mar '26 Sep '26
P/E
Price / sales (P/S)
0.0 2.1 4.3 Mar '23 Sep '23 Mar '24 Sep '24 Mar '25 Sep '25 Mar '26 Sep '26
P/S

Frequently asked questions

Is PRLB growing its revenue and profit?

Over the past 5 years, Proto Labs Inc's revenue has grown 4.2% per year, and net income declined 16.0% per year. These are computed facts, not advice.

How much debt does PRLB have?

As of FY2025, Proto Labs Inc reported — of total debt against $111M of cash.

What is PRLB's profit margin?

In FY2025, gross margin was 44.5%, operating margin 4.7%, and net margin 4.0%.

What is PRLB's P/E ratio?

Proto Labs Inc's P/E (TTM) is 45.84 as of the 2026-11-02 close — market cap ÷ net income over the trailing twelve months where four consecutive quarters are reported, otherwise the latest fiscal year, the same figure as on the PRLB stock page. The valuation chart above sets each month-end's price against the latest annual net income instead, so its latest point (about 75.6× as of Nov '26) can differ. These are computed facts, not advice.

Where does this data come from?

All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.

Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), split-adjusted; price return — dividends not reinvested · growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price against the latest annual filing. Informational only — not investment advice.